Published: 2019-02-23

Anti-tumor effect of fruit rind of Myristica malabarica in an Ehrlich ascites carcinoma model

Chandrakana Bandyopadhyay, Alak Manna, Soumita De, Nafisha Yasmin, Ajay K. Bauri, Subrata Chattopadhyay, Mitali Chatterjee


Background: Among the various modalities of anti-cancer treatment, cancer chemotherapy plays a very vital role. The alarming side effects being its main drawback leads to relentless research for newer agents. A new natural agent with promising anti-cancer properties from in-vitro studies leads to this study. Here we have evaluated the anti-tumor activity of a crude extract of fruit rind of Myristica malabarica in an Ehrlich ascites carcinoma model in mice.

Methods: A murine model of cancer was established with i.p. inoculation of Ehrlich Ascites carcinoma (EAC) cells; animals were divided into five groups (including normal control) to observe the inhibitory effect of a crude extract of the fruit rind of Myristica malabarica/rampatri (0-100mg/kg b.w. i.p.) as compared with methotrexate (0.4mg/kg bw., i.p.). Blood and ascitic fluid were collected on the 10th day for analysis.

Results: In the EAC model, there was an increase in tumor volume, tumor weight, and tumor packed cell volume, which was decreased by rampatri (50 and 100mg/kg bw) along with an increase in the mean survival time (MST). Rampatri caused minimal alterations in hematological parameters, renal functions remained unchanged but an increase in hepatic SGOT was demonstrated.

Conclusions: The crude extract of rampatri (containing Malabaricones) exhibited significant anti-tumor activity with minimal effect on hematological and renal functions.


Anti-tumor, Ehrlich ascites carcinoma, Malabaricones, Myristica malabarica, Rampatri

Full Text:



Morita T, Jinno K, Kawagishi H, Arimoto Y, Suganuma H, Inakuma T, et al. Hepatoprotective effect of Myristica from nutmeg (Myristica fragrant) on lipopolysaccharide/d-galactosamine-induced liver injury. J Agric Food Chem. 2003;51:1560-5.

Banerjee D, Bandyopadhyay SK, Bauri AK, Chattopadhyay S. Healing properties of malabaricone B and malabaricone C, against indomethacin-induced gastric ulceration and mechanism of action. Eur J Pharmacol. 2008;578:300-12.

Sen R, Bauri AK, Chattopadhyay S, Chatterjee M. Antipromastigote activity of the malabaricones of Myristica malabarica(Rampatri) Phytother Res. 2007;21:592-5.

Manna A, Saha P, Sarkar A, Mukhopadhyay D, Bauri AK, Kumar D, et al. Malabaricone-A induces a redox imbalance that mediates apoptosis in U937 cell line. PLoS One. 2012;7:e36938.

Patro BS, Bauri AK, Mishra S, Chattopadhyay S. Antioxidant activity of Myristica malabarica extracts and their constituents. J Agric Food Chem. 2005;53:6912-8.

Tyagi M, Bhattacharyya R, Bauri AK, Patro BS, Chattopadhyay S. DNA damage dependent activation of checkpoint kinase-1 and mitogen-activated protein kinase-p38 are required in malabaricone C-induced mitochondrial cell death. Biochim Biophys Acta. 2014;1840:1014-27.

Bala A, Kar B, Haldar PK, Mazumder UK, Bera S. Evaluation of anticancer activity of Cleome gynandraon Ehrlich's Carcinoma treated mice. J Ethnopharm. 2010;129:131-4.

Manna A, Bauri AK, Chattopadhyay S, Chatterjee M. Effectiveness of Malabaricone-A in a multidrug resistant cell line is mediated via generation of redox imbalance. Anticancer Agents Med Chem. 2015;15:1156-63.

Manna A, De Sarkar S, De S, Bauri AK, Chattopadhyay S, Chatterjee M. The variable chemotherapeutic response of Malabaricone-A in leukemic and solid tumor cell lines depends on the degree of redox imbalance. Phytomed. 2015;22:713-23.

Manna A, Chattopadhyay S, Chatterjee M. Plant derived pro-oxidants as potential anti-cancer therapeutics. 2016; Studies in Natural Products Chemistry; Atta-ur- Rahmaned (Bioactive Natural Products), Elsevier, Amsterdam; 2016;81-92.

Haldar PK, Kar B, Bala A, Bhattacharya S, Mazumder UK. Antitumor activity of Sansevieria roxburghiana rhizome against Ehrlich ascites carcinoma in mice. Pharm Biol. 2010;48:1337.

KunduSen S, Gupta M, Mazumder UK, Haldar PK, Saha P, Bala A et al. Antitumor activity of Citrus maxima (Burm.) Merr. Leaves in Ehrlich’s Ascites Carcinoma Cell-treated mice. ISRN Pharmacol. 2011;138737.

Ozaslan M, Karagoz ID, Kilic IH, Guldur ME. Ehrlich ascites carcinoma. J Home. 2011;10:13.

Manjunatha BK, Mankani KL, Mukunda SK, Divakara R, Sridar BK and Paul K. Antioxidant and hepatoprotective effect of Myristica malabarica seed aril extracts on carbon tetrachloride induced hepatic damage. Global J Biotechnol Biochem. 2011;6:25-30.